IGF-I (30-41); Insulin-like Growth Factor I (30-41) spans a region implicated in receptor recognition and binding specificity. The fragment captures side-chain interactions that stabilize local secondary structure. Researchers use it in mapping contact interfaces, designing analogs, and studying degradation pathways. Its defined length facilitates NMR, MS, and computational analysis.
CAT No: I01005
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.